Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain
Crossref DOI link: https://doi.org/10.1007/s00520-014-2435-5
Published Online: 2014-09-14
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ahmedzai, Sam H.
Leppert, Wojciech
Janecki, Marcin
Pakosz, Artur
Lomax, Mark
Duerr, Heike
Hopp, Michael
License valid from 2014-09-14